R. Mulvey

发表

Endoplasmic Reticulum Stress Links Dyslipidemia to Inhibition of Proteasome Activity and Glucose Transport by HIV Protease Inhibitors

R. Parker, O. Flint, R. Mulvey, 2005, Molecular Pharmacology.

Cyclic amine sulfonamides as linkers in the design and synthesis of novel human beta(3) adrenergic receptor agonists.

R. Mulvey, V. Wong, E. Largis, 2003, Bioorganic & medicinal chemistry letters.

Novel (4-piperidin-1-yl)-phenyl sulfonamides as potent and selective human beta(3) agonists.

M. Malamas, R. Mulvey, A. Oliphant, 2001, Bioorganic & medicinal chemistry.

4-Aminopiperidine ureas as potent selective agonists of the human beta(3)-adrenergic receptor.

R. Mulvey, S. Han, M. Ashwell, 2001, Bioorganic & medicinal chemistry letters.

Novel substituted 4-aminomethylpiperidines as potent and selective human beta3-agonists. Part 2: arylethanolaminomethylpiperidines.

R. Mulvey, R. Steffan, M. Ashwell, 2002, Bioorganic & medicinal chemistry letters.

(4-Piperidin-1-yl)phenyl amides: potent and selective human beta(3) agonists.

R. Mulvey, A. Oliphant, J. Ellingboe, 2001, Journal of medicinal chemistry.

New oxadiazolidinedione derivatives as potent and selective human beta3 agonists.

M. Malamas, R. Mulvey, J. Ellingboe, 2001, Bioorganic & medicinal chemistry letters.

New Oxadiazolidinedione Derivatives as Potent and Selective Human β3 Agonists.

M. Malamas, R. Mulvey, J. Ellingboe, 2001 .

2,4-Thiazolidinediones as potent and selective human beta3 agonists.

A Oliphant, M. Malamas, R. Mulvey, 2001, Bioorganic & medicinal chemistry letters.